CLINICAL ROLE -
Novel Approaches in Improving HF Management
Biomarkers and Future Strategies in Heart Failure
Improving Inpatient to Outpatient HF Care Transitions
Switching HF Medications in the Inpatient Setting
Heart Failure Management: Updating Hospital Order Sets
Hospital Pharmacy Perspective: HF Medication Review
Acute Decompensated Heart Failure Hospitalization
The Role of Sacubitril/Valsartan in HFrEF
Angiotensin Receptor Neprilysin Inhibition in Heart Failure
The Role of Ivabradine in Heart Failure Management
Blocking the RAAS Pathway in Heart Failure
Heart Failure Pathways and the Role of Beta Blockers
The Usefulness of Measuring BNP Levels in Heart Failure
Characteristics of Patients with HFrEF
The Underappreciated Burden of Heart Failure
Streamlining Relationships Among Specialty Pharmacy Stakeholders
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.
Biosimilars in Specialty Pharmacy
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Optimal Management Programs Vital to Specialty Patient Success
Rebekah L. Hanson, PharmD, BCPS, BCACP, discusses the elements of an effective patient management program in specialty pharmacy.
Overcoming High Out-of-Pocket Costs in Specialty Pharmacy
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how pharmacies can help patients manage high drug costs.
Managing Effective Specialty Drug Distribution
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.
Pharmacy Week in Review: April 13, 2017
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Alignment Between Specialty Pharmacy and ACOs
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how specialty pharmacies can help achieve the goals of accountable care organizations.
Helping Patients Manage High Medication Co-pays
Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.
Pharmacy Week in Review: April 7, 2017
Limitations in Prior Authorizations for Specialty Drugs
Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.
How Will Drug Costs Impact the Specialty Pharmacy Patient Experience?
Grant E. Knowles, PharmD, discusses how the projected growth in specialty drug spending may change the patient experience in the years ahead.
How to Improve Adherence to Specialty Drugs
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how to optimize a drug adherence program in specialty pharmacy.
Pharmacy Week in Review: March 31, 2017
What Should Pharmacists Advise Patients About Methotrexate and B1?
Judy Sommers Hanson, PharmD, FAPhA, chats with Pharmacy Times about the important role that pharmacists can play in educating the public on B1 and methotrexate use.
Are There Interactions Between Certain Medications, Nutraceuticals That Pharmacists Should Counsel About?
Pharmacists need to remain aware of certain interactions that can occur with medications and nutraceuticals.
